The Boston Pediatric Device Strategic Challenge

 
 

What is the Boston Pediatric Device Strategic Partner Challenge?

Pediatric device development and evaluation has been recognized as a critical need to improve the lives and welfare of children with congenital and acquired illnesses. The numerous challenges faced by device developers and manufacturers have resulted in a large unmet need for pediatric devices. The Boston Pediatric Device Strategic Partner Challenge seeks to support and advance innovative pediatric medical devices by providing Challenge winners a combination of up to $50,000 in funding per grant award, and/or mentorship and strategic support from Challenge co-hosts the Boston Pediatric Device Consortium and Boston Children’s Innovation & Digital Health Accelerator and leading medical device industry partners. Up to $250,000 will be awarded. Technologies for any medical device that serves the pediatric population are accepted, with a specific interest in five focus areas: cardiovascular/endovascular, asthma, obesity, sepsis and general pediatrics.

Funded in part by the FDA Office of Orphaned Products Development through a grant to the Boston Pediatric Device Consortium.


Who is hosting the challenge?

The Boston Pediatric Device Strategic Partner Challenge is co-hosted by the Boston Pediatric Device Consortium (BPDC) and Boston Children’s Hospital’s Innovation & Digital Health Accelerator (IDHA) with support from strategic partners: Boston Scientific, CryoLife, Edwards Lifesciences, Health Advances, Johnson & Johnson Innovation, Smithwise and Ximedica.


What medical devices are eligible?

Submissions for any stage of development are encouraged, from concept through launched product, for devices classified as pediatric medical devices in accordance with section 201(h) of the Federal Food Drug & Cosmetic Act. The Challenge will accept any medical device that serves the pediatric population, with a specific interest in five focus areas: cardiovascular/endovascular, asthma, obesity, sepsis and general pediatrics.


When does the challenge open and close?

The national call for applications is open September 11 through 11:59 p.m. ET on October 20, 2017, at www.bostonpdc.org. Finalists will be selected and invited to pitch their device in Boston in early December and Challenge awardees will be announced January 2018.

 
What will awardees receive?

Awardees will receive up to $50,000 in funding per grant award, and/or mentorship and support from the Challenge co-hosts and strategic partners. Support may range from product manufacturing support, to business plan development, to partnerships with industry leaders. Up to $250,000 will be awarded. The Challenge is funded in part by the FDA Office of Orphan Products Development through a grant to the Boston Pediatric Device Consortium.


How are entries judged?

Applicants will be reviewed and vetted by the BPDC and strategic partners, including leading clinical, business, and technical experts.  Review criteria include:

  • FDA Pediatric Device Criteria
  • Team Qualifications
  • Clinical Impact
  • Market Opportunity
  • Business Model
  • Plan for use of funds/leveraging partnership
  • Defensible IP
  • If Applicable - Partner and Startup Fit/Match


How do I apply?

Interested applicants can review the Challenge rules here. Applications must be submitted by 11:59 p.m. ET on Friday, October 20, 2017. Questions can be submitted to BPDC@childrens.harvard.edu.

Click here to preview the application questions. 
 

What is the Boston Pediatric Device Consortium?

The Boston Pediatric Device Consortium (BPDC) provides expertise and resources to device developers and manufacturers at each of the steps necessary for novel pediatric device development, in order to accelerate the pace of innovation. The BPDC is a collaborative of experts in engineering, clinical sciences, clinical trials design and performance, device development specialists, and industry partners whose primary goal is to develop and evaluate novel therapies for children. Leading the BPDC is Pedro del Nido, MD, the Chief of the Department of Cardiac Surgery at Boston Children’s Hospital, the William E. Ladd Professor of Child Surgery at Harvard Medical School, and medical device entrepreneur.

The Innovation and Digital Health Accelerator (IDHA) is a cross-functional team within Boston Children’s Hospital with expertise in software development, data analytics, clinical care and lean startup practices, working together to accelerate innovations and technologies from concept to global deployment. Through the creation of IDHA, Boston Children’s reinforces a commitment to, and investment in, pediatric innovation.